JP2024535467A5 - - Google Patents
Info
- Publication number
- JP2024535467A5 JP2024535467A5 JP2024519581A JP2024519581A JP2024535467A5 JP 2024535467 A5 JP2024535467 A5 JP 2024535467A5 JP 2024519581 A JP2024519581 A JP 2024519581A JP 2024519581 A JP2024519581 A JP 2024519581A JP 2024535467 A5 JP2024535467 A5 JP 2024535467A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- level
- psoriatic arthritis
- proteins
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163250735P | 2021-09-30 | 2021-09-30 | |
| US63/250,735 | 2021-09-30 | ||
| US202163257407P | 2021-10-19 | 2021-10-19 | |
| US63/257,407 | 2021-10-19 | ||
| US202263330308P | 2022-04-12 | 2022-04-12 | |
| US63/330,308 | 2022-04-12 | ||
| PCT/US2022/045187 WO2023055901A2 (en) | 2021-09-30 | 2022-09-29 | Methods for determining responsiveness to tyk2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535467A JP2024535467A (ja) | 2024-09-30 |
| JP2024535467A5 true JP2024535467A5 (OSRAM) | 2025-10-01 |
Family
ID=84359787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519581A Pending JP2024535467A (ja) | 2021-09-30 | 2022-09-29 | Ｔｙｋ２阻害剤に対する応答性を決定する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240390369A1 (OSRAM) |
| EP (1) | EP4408527A2 (OSRAM) |
| JP (1) | JP2024535467A (OSRAM) |
| KR (1) | KR20240070634A (OSRAM) |
| WO (1) | WO2023055901A2 (OSRAM) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2588105A1 (en) | 2010-07-01 | 2013-05-08 | Cellzome Limited | Triazolopyridines as tyk2 inhibitors |
| KR20130051507A (ko) | 2010-09-15 | 2013-05-20 | 에프. 호프만-라 로슈 아게 | 아자벤조티아졸 화합물, 조성물 및 사용 방법 |
| JPWO2013125543A1 (ja) | 2012-02-20 | 2015-07-30 | 武田薬品工業株式会社 | 複素環化合物 |
| EP2832734A4 (en) | 2012-03-28 | 2015-08-26 | Takeda Pharmaceutical | HETEROCYCLIC COMPOUND |
| US9296725B2 (en) | 2012-05-24 | 2016-03-29 | Cellzome Limited | Heterocyclyl pyrimidine analogues as TYK2 inhibitors |
| AU2013341186B2 (en) | 2012-11-08 | 2017-03-30 | Bristol-Myers Squibb Company | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses |
| EP3029031A4 (en) | 2013-07-30 | 2017-01-11 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| CN105793245B (zh) | 2013-09-03 | 2018-03-20 | 萨勒姆有限公司 | 药物化合物 |
| WO2015091584A1 (en) | 2013-12-18 | 2015-06-25 | F. Hoffmann-La Roche Ag | Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors |
| JP6802263B2 (ja) | 2015-09-02 | 2020-12-16 | ニンバス ラクシュミ， インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| CN115448916B (zh) | 2016-10-14 | 2026-04-28 | 武田药品工业株式会社 | Tyk2抑制剂及其用途 |
| JP7082120B2 (ja) | 2016-10-21 | 2022-06-07 | ニンバス ラクシュミ， インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| WO2019023468A1 (en) | 2017-07-28 | 2019-01-31 | Nimbus Lakshmi, Inc. | TYK2 INHIBITORS AND USES THEREOF |
-
2022
- 2022-09-29 EP EP22806028.1A patent/EP4408527A2/en active Pending
- 2022-09-29 WO PCT/US2022/045187 patent/WO2023055901A2/en not_active Ceased
- 2022-09-29 KR KR1020247013861A patent/KR20240070634A/ko active Pending
- 2022-09-29 US US18/696,915 patent/US20240390369A1/en active Pending
- 2022-09-29 JP JP2024519581A patent/JP2024535467A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| So et al. | A pilot study of IL-1 inhibition by anakinra in acute gout | |
| Sánchez-Aguilar et al. | Effect of rosuvastatin on cytokines after traumatic head injury | |
| Takeuchi et al. | Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study) | |
| JP2013541010A (ja) | グラチラマーアセテートに対する臨床的な反応の予測可能なバイオマーカーとしてのサイトカインバイオマーカー | |
| Ghantous et al. | The efficiency of extended postoperative antibiotic prophylaxis in orthognathic surgery: a prospective, randomized, double-blind, placebo-controlled clinical trial | |
| EA034864B1 (ru) | Способ лечения эозинофильной астмы со степенью тяжести от умеренной до тяжёлой | |
| KR20170045750A (ko) | 폐 사르코이드증 치료 방법 | |
| JP2023527542A5 (OSRAM) | ||
| Jhun et al. | Vitamin D attenuates pain and cartilage destruction in OA animals via enhancing autophagic flux and attenuating inflammatory cell death | |
| Somisetty et al. | Comparing the efficacy of intra-articular platelet-rich plasma and corticosteroid injections in the management of frozen shoulder: a randomized controlled trial | |
| Baggio et al. | Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans | |
| Son et al. | SAMiRNA targeting amphiregulin alleviate total-body-irradiation-induced renal fibrosis | |
| Li et al. | Cannabidiol-loaded hydrogel microneedle patches inhibit TRIM14/TRAF3/NF-κB axis for the treatment of psoriasis | |
| Yang et al. | Inhibition of hepatitis B virus through PPAR-JAK/STAT pathway modulation by electroacupuncture and tenofovir disoproxil fumarate combination therapy | |
| US6258798B1 (en) | Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin | |
| Bulanov et al. | Successful Treatment With High-Dose Colchicine of a 101-Year-Old Patient Diagnosed With COVID-19 After an Emergency Cholecystectomy | |
| Michot et al. | A double-blind clinical trial to determine if an interaction exists between diclofenac sodium and the oral anticoagulant acenocoumarol (nicoumalone) | |
| JP3916563B2 (ja) | Ｐ物質の投与を含む治療方法 | |
| JP6912875B2 (ja) | ＥｒｂＢ４＋炎症性マクロファージによって媒介される疾患の治療方法 | |
| CN115175678B (zh) | 使用btk抑制剂及其组合治疗dlbcl的方法 | |
| Kim et al. | Improvement effect of soyeom pharmacopuncture on gout via NLRP3 inflammasome regulation | |
| RU2742116C1 (ru) | Противокоронавирусное средство для комбинированной терапии COVID-19 (SARS-CoV-2). | |
| IL314179A (en) | Compositions and methods for the treatment of depression | |
| Breijo-Márquez | Misuse of the Drug Acenocoumarol in a Population of 250 Inhabitants with Non-valvular Atrial Fibrillation Assessed in a Region of Southeaster of Spain | |
| US10213444B2 (en) | Composition and method for treating bipolar disorder |